D-0257-2025 Class II Terminated

Recalled by Nephron Sterile Compounding Center LLC — West Columbia, SC

FDA drug recall D-0257-2025 was initiated by Nephron Sterile Compounding Center LLC on Feb 10, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port. The recall status is terminated (terminated Aug 14, 2025). Affected quantity: 4,190 bottles.

Recall details

Product Type
Drugs
Report Date
Mar 19, 2025
Initiation Date
Feb 10, 2025
Termination Date
Aug 14, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,190 bottles

Product description

Sodium Chloride Injection 9%, USP, 500 mL, Single-Dose IV Bottle, Rx Only, nephron, 503B outsourcing facility, West Columbia, SC 29172, NDC: 69374-334-50

Reason for recall

Lack of Assurance of Sterility: There is a potential for leakage at the IV bottle port.

Distribution pattern

US Nationwide.

Code information

Lot # NA4008B, exp. date 03/03/2025 Lot # NA4005B & NA4005E, exp. date 02/20/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0257-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0257-2025. Report a data issue: hello@regdatalab.com.